The Marijuana Rescheduling Hearing Is Over — Now One Judge Decides

The marijuana rescheduling hearing is over. After two weeks of testimony at DEA headquarters in Arlington, the evidentiary hearing on moving marijuana to Schedule III wrapped up on July 15 — and here is what a searcher actually wants to know: Chief Administrative Law Judge Derek Julius gave participants until August 17 to file post-hearing briefs of up to 50 pages, after which he writes a recommendation. The final call belongs to the DEA administrator. No timeline was given for either. Two years of process now fits in a 50-page brief.

marijuana rescheduling

The hearing itself was one of the strangest proceedings in administrative-law history: the DEA — the agency that spent five decades defending Schedule I — was the proponent of rescheduling, while the seven outside designated participants it selected (NDASA, the Tennessee Bureau of Investigation, SAM, the states of Nebraska, Idaho, Indiana and Louisiana, DUID Victim Voices, Kenneth Finn and Phillip Drum) all opposed or doubted the move. The government’s own witnesses spent two weeks defending marijuana’s medical value and its relative safety compared to alcohol and opioids. The states got the last word on July 14. Then the record closed.

What happens after the marijuana rescheduling hearing

Three steps remain. Briefs by August 17 — closing arguments, maximum 50 pages, per the judge’s order as reported. Then Julius writes his recommended ruling on whether adult-use marijuana joins the state-licensed medical products that moved to Schedule III back in April. Then the DEA administrator decides — and whatever he decides gets challenged in a federal circuit court, because this is cannabis law and nothing is ever finished.

Industry advocates came away encouraged, and honestly, they should be: the record skews heavily toward the medical case, because the proponent built it that way. We covered the lopsided structure when the hearing hit week two — the industry never got a seat, but neither did it need one. The prohibitionists were left cross-examining the government’s pain doctors.

Why operators should care about a brief deadline

Because everything downstream of Schedule III — the 280E tax fight, banking pressure, research access — keys off this record. And because Congress is circling the same target from the other side: one day after the record closed, Schumer reintroduced full descheduling. Meanwhile the Pentagon reminded everyone that rescheduling changes nothing for troops. Schedule III is a tax status, not legalization — and the space between those two things is where the next two years of cannabis law happens.

Marijuana rescheduling FAQ

Did the DEA reschedule marijuana? Medical: yes — state-licensed medical cannabis products moved to Schedule III in April 2026. Adult-use: not yet; that is what this hearing record will decide.

When will the final rescheduling decision come? No deadline exists. Briefs are due August 17; the ALJ recommendation and administrator decision have no announced timeline.

How we got here: a two-year timeline

For readers just joining: HHS recommended Schedule III in August 2023 after its scientific review found credible evidence of medical use. The DOJ published its proposed rule, hundreds of thousands of public comments followed, and litigation over the hearing’s structure ate most of 2025. President Trump’s December executive order pushed the process forward, the Blanche order moved state-licensed medical products in April, and the adult-use question went to this summer’s evidentiary hearing. Every step was fought, appealed, or delayed — and every step still moved the same direction. That’s the pattern worth betting on: slow, contested, forward.

One more wrinkle lawyers will care about: because the DEA is both the proponent of the rule and the agency whose administrator makes the final call, any final order will face immediate challenge on process grounds — the same D.C. Circuit fight that has shadowed this proceeding all year. The brief deadline starts that clock. Whatever Julius recommends, assume the real finish line is a federal appeals court in 2027.

Watch the full episode

Watch the full Cannabis Legalization News episode on YouTube →

Original sources

Picture of Thomas Howard

Thomas Howard

a seasoned cannabis business attorney, entrepreneur, and advocate with over a decade of hands-on experience navigating complex cannabis regulations across the United States. As the founder of Cannabis Industry Lawyer and co-host of Cannabis Legalization News, Tom has helped clients win cannabis licenses in multiple states, advised startups from seed to sale, and litigated key industry cases involving constitutional challenges and regulatory disputes. He’s personally built and launched cannabis businesses, giving him a rare combination of legal expertise and real-world operational insight. Tom has studied thousands of pages of cannabis laws and rules, testified on legalization issues, and regularly appears in media to break down developments in plain English. His mission: to fight outdated prohibition, empower entrepreneurs, and provide trustworthy, actionable information to anyone building a future in the legal cannabis industry.
Picture of Thomas Howard

Thomas Howard

a seasoned cannabis business attorney, entrepreneur, and advocate with over a decade of hands-on experience navigating complex cannabis regulations across the United States. As the founder of Cannabis Industry Lawyer and co-host of Cannabis Legalization News, Tom has helped clients win cannabis licenses in multiple states, advised startups from seed to sale, and litigated key industry cases involving constitutional challenges and regulatory disputes. He’s personally built and launched cannabis businesses, giving him a rare combination of legal expertise and real-world operational insight. Tom has studied thousands of pages of cannabis laws and rules, testified on legalization issues, and regularly appears in media to break down developments in plain English. His mission: to fight outdated prohibition, empower entrepreneurs, and provide trustworthy, actionable information to anyone building a future in the legal cannabis industry.

Get Our Email

Sign up for our newsletter to receive product updates, exclusive discounts, and VIP webinar access

Related Posts

Subscribe to our Newsletter